Please try another search
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Jan-Eric Österlund | 79 | 2024 | Independent Chairman |
Lars Lind | 83 | 2024 | Independent Director |
Alain Herrera | 74 | 2017 | Independent Director |
Sten Nilsson | 76 | 2017 | Independent Director |
Helena Taflin | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review